在晚期胰腺癌中进行动脉内化疗:文学评论
K Cherchenko1, Y Ostapenko1, V Patsko1
1State Non-commercial Enterprise "National Cancer Institute", Kyiv, Ukraine.
Experimental oncology
|March 6, 2026
概括
动脉输液化疗可以改善晚期胰腺癌的生存率和症状控制. 这种治疗提供了较高的局部药物度,降低了全身毒性,对精选患者显示出有前途.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 医学瘤学 医学瘤学
背景情况:
- 胰腺癌的5年生存率很低 (大约5年). 7%) 和无法切除的病例的治疗选择有限.
- 目前的第三线治疗缺乏明确的建议,原因是患者的病情和低效率.
- 动脉输液提供局部药物输送,可能增加疗效并减少全身毒性.
研究的目的:
- 评估动脉输液化疗对胰腺癌的疗效和安全性.
- 为了比较动脉输液方案与晚期疾病的全身化疗.
主要方法:
- 采用了动脉内治疗方案,主要是5-甲和凝.
- 在对照组中比较了动脉输液与全身化疗的结果.
主要成果:
- 与全身化疗相比,动脉输注显示出更高的整体存活率.
- 通过动脉输液观察到更高的应答率和更好的局部症状控制.
- 动脉输液方法表现出有利的安全性和良好的耐受性.
结论:
- 动脉输液化疗是局部晚期或仅肝脏转移性胰腺癌的有希望的治疗方法.
- 这种方法适用于缺乏其他选择的具有充足性能状态的患者.
- 需要进行进一步的临床试验,以探索动脉输液在胰腺癌管理中的全部潜力.
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...